Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Feb;45(2):300–303. doi: 10.1038/bjc.1982.47

Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.

C R Pinkerton, S G Welshman, J M Bridges
PMCID: PMC2010896  PMID: 6949608

Full text

PDF
300

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERTINO J. R., DONOHUE D. R., GABRIO B. W., SILBER R., ALENTY A., MEYER M., HUENNEKENS F. M. Increased level of dihydrofolic reductase in leucocytes of patients treated with amethopterin. Nature. 1962 Jan 13;193:140–142. doi: 10.1038/193140a0. [DOI] [PubMed] [Google Scholar]
  2. Calvert A. H., Bondy P. K., Harrap K. R. Some observations on the human pharmacology of methotrexate. Cancer Treat Rep. 1977 Dec;61(9):1647–1656. [PubMed] [Google Scholar]
  3. Djerassi I., Farber S., Abir E., Neikirk W. Continuous infusion of methotrexate in children with acute leukemia. Cancer. 1967 Feb;20(2):233–242. doi: 10.1002/1097-0142(1967)20:2<233::aid-cncr2820200209>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  4. Freeman-Narrod M., Gerstley B. J., Engstrom P. F., Bornstein R. S. Comparison of serum concentrations of methotrexate after various routes of administration. Cancer. 1975 Nov;36(5):1619–1624. doi: 10.1002/1097-0142(197511)36:5<1619::aid-cncr2820360514>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  5. Goldman I. D. Effects of methotrexate on cellular metabolism: some critical elements in the drug-cell interaction. Cancer Treat Rep. 1977 Jul;61(4):549–558. [PubMed] [Google Scholar]
  6. Harrap K. R., Hill B. T., Furness M. E., Hart L. I. Sites of action of amethopterin: intrinsic and acquired drug resistance. Ann N Y Acad Sci. 1971 Nov 30;186:312–324. doi: 10.1111/j.1749-6632.1971.tb46986.x. [DOI] [PubMed] [Google Scholar]
  7. Huffman D. H., Wan S. H., Azarnoff D. L., Hogstraten B. Pharmacokinetics of methotrexate. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):572–579. doi: 10.1002/cpt1973144part1572. [DOI] [PubMed] [Google Scholar]
  8. Kearney P. J., Light P. A., Preece A., Mott M. G. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia. Cancer Chemother Pharmacol. 1979;3(2):117–120. doi: 10.1007/BF00254982. [DOI] [PubMed] [Google Scholar]
  9. Noble W. C., White P. M., Baker H. Assay of therapeutic doses of methotrexate in body fluids of patients with psoriasis. J Invest Dermatol. 1975 Feb;64(2):69–76. doi: 10.1111/1523-1747.ep12510255. [DOI] [PubMed] [Google Scholar]
  10. Pinkerton C. R., Welshman S. G., Dempsey S. I., Bridges J. M., Glasgow J. F. Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia. Br J Cancer. 1980 Oct;42(4):613–615. doi: 10.1038/bjc.1980.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Scott A. K., Hawksworth G. M. Clinical pharmacology: drug absorption. Br Med J (Clin Res Ed) 1981 Feb 7;282(6262):462–463. doi: 10.1136/bmj.282.6262.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Simone J. Acute lymphocytic leukemia in childhood. Semin Hematol. 1974 Jan;11(1):25–39. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES